Frequently asked questions

HealthTech consulting helps healthcare organizations, pharma companies, MedTech firms, and investors navigate the rapidly evolving intersection of healthcare and technology. It covers areas such as AI strategy, digital health transformation, HealthTech due diligence, and technology scouting. At HGM Advisory, we activate specialized experts from our network for each engagement — ensuring deep domain expertise for every challenge.

AI is transforming healthcare across multiple domains. In clinical settings, AI-powered clinical decision support tools (like OpenEvidence and AMBOSS Lisa) help physicians make faster, evidence-based decisions. In radiology, over 1,300 AI algorithms have been FDA-approved for diagnostic imaging. AI is also scaling in outpatient care through agentic AI (automated scribes, billing, scheduling) and in pharma R&D for drug discovery and clinical trial optimization. Hospital IT is being reshaped by AI-native platforms challenging legacy EHR systems.

HealthTech due diligence is the systematic assessment of a digital health or health technology company's business model, technology stack, regulatory positioning, competitive landscape, clinical evidence, and operational capabilities. It is typically conducted by investors (VC, PE, growth equity) evaluating a potential investment, or by corporates assessing acquisition targets or partnership candidates. HGM Advisory brings specialized HealthTech expertise to due diligence processes, drawing on our network of clinicians, technologists, and industry operators.

Unlike traditional consulting firms with a fixed team, a decentralized advisory network operates by activating the right experts for each engagement. HGM Advisory has built a curated network of 50+ independent HealthTech experts — each a practitioner in their domain (clinicians, hospital CIOs, venture capitalists, digital health founders, pharma strategists, health economists). When a client brings a challenge, we identify and assemble the best-fit team from this network, ensuring deep expertise rather than generalist coverage.

We work with three main client segments: Corporates (pharma companies like Novo Nordisk, Pfizer, and AstraZeneca, as well as MedTech companies and health insurers), Investors (VC firms, growth equity, and private equity conducting HealthTech due diligence), and Start-ups & Scale-ups (HealthTech companies at every stage seeking strategic guidance, market entry support, or investor readiness).

We design and deliver customized HealthTech & AI trainings for corporate teams. These range from half-day executive briefings on AI in healthcare to multi-day deep dives covering the HealthTech landscape, business models, regulatory frameworks, and evaluation methodologies. Our trainings are interactive and gamified — teams work with real HealthTech case studies and leave with practical frameworks they can apply immediately. Past clients include global pharma companies, health insurers, and MedTech innovation teams.

Our AI strategy work follows a structured approach: First, we assess the organization's current AI maturity and competitive positioning. Then we map the relevant AI landscape (clinical AI, operational AI, or R&D AI depending on the client). We identify high-impact use cases, evaluate build-vs-buy-vs-partner options, and develop a phased roadmap with clear milestones. Throughout the process, we address regulatory considerations (EU AI Act, MDR, FDA) and change management requirements. Our network includes AI researchers, clinicians, and operators who bring practical implementation experience.

HGM Advisory is headquartered in Berlin, Germany, and operates across 15+ countries. Our network includes experts based in Germany, France, the Netherlands, Italy, Spain, Sweden, India, and the United States. We have particular depth in European healthcare markets (DACH, Nordics, Southern Europe, Benelux) and growing coverage in the US and Asia. Our multilingual team conducts engagements in English, German, French, Dutch, Italian, Spanish, and Swedish.